Dr. Bette Kim, MD

Dr. Kim practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Kim's NPI, 1023095171, was assigned on December 29, 2005. Dr. Kim graduated from New York University School of Medicine in 1999. Dr. Kim holds New York license 218819.

Dr. Kim's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Kim's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Kim is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Kim to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kim practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Kim's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Kim is licensed in New York.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, chronic hypertension, coronary artery disease, heart failure, heart valve disorders and high cholesterol among the conditions Dr. Kim treats.

CMS data shows 2,103 Medicare services from Dr. Kim across 13 procedure codes in 2024, for 1,211 Medicare patients. Medicare paid $94,845 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,211 Medicare patients who saw Dr. Kim in 2024. The largest group is 75 to 84, with 455 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kim's median patient age at 66, with 47% women.

In 2024, Dr. Kim wrote 2,325 Medicare Part D claims for 228 patients. 74% of them were for generic drugs. CMS names the drug for 2,010 of them, across 39 drugs with 11 or more claims each, at $1,373,320 in total drug cost. In 2023, CMS named 1,852 claims across 42 drugs.

Dr. Kim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kim as offering telehealth.

Dmand AI links 19 papers to Dr. Kim, published from 2012 to 2024. 2013 was the busiest year, with 4. The most frequent topics are Cardiomyopathy, Hypertrophic, Ventricular Outflow Obstruction and Echocardiography. Dr. Kim has published most often in J Am Coll Cardiol. Dr. Kim's most frequent co-authors are Mark V. Sherrid, MD, Daniel George Swistel, MD and Sandhya K. Balaram.

Dmand AI links Dr. Kim to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Aortic Stenosis, Subvalvular and Cardiomyopathy, Hypertrophic.

CMS Open Payments shows 98 general payments to Dr. Kim from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $755.

Dmand AI lists 1 award for Dr. Kim, most recently CMS Stage 1 EHR in 2013.

Dr. Kim graduated from New York University School of Medicine in 1999.

Dr. Kim is in network with 18 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.